Abstract
Background:
Female sex workers (FSWs) in most societies run a high risk of health problems, including sexually transmitted infections (STIs) such as viral infections and syphilis. The present study examines the prevalence of viral infections and syphilis among FSWs.
Methods:
This cross-sectional study recruited 100 female sex workers (April 2019 to April 2020) who visited the Counseling Center for Behavioral Diseases or were selected via purposeful (snowball) sampling. A questionnaire (demographic information and STI risk factors) was completed in a face-to-face interview with the participants. Blood samples were then taken to test the markers for HBV, HCV Ab, HIV Ab, Rapid Plasma Reagin (RPR) for syphilis and a PCR was taken to test for HPV (in vaginal sex workers from the cervix and anal sex workers from the anal region). The data were analyzed in Stata 14.
Results:
Among 100 FSWs, 6 (6%) were infected with HIV, 1 (1%) with hepatitis B, and 2 (2%) were anti-HCV positive. 1 (1%) participant was suspected of having syphilis. Based on the PCR tests, 16 (16%) participants were infected with HPV. Moreover, 68 (68%) FSWs reported having unprotected sex.
Conclusion:
Due to the prevalence of viral infections and syphilis and unprotected sex in FSWs, immediate preventive measures are critical for this vulnerable group to control the transmission of these viral infections in society.
Key Words: Prevalence, Female sex workers, HIV, Sexually transmitted infection, Iran.
Female sex workers (FSWs) in different societies are exposed to social harms, including poverty, violence, exploitation, discrimination, drug use, and health-related problems, including unintended pregnancy and sexually transmitted infections (STIs) such as viral and bacterial infections (1). More than 30 different bacteria, viruses and parasites are known to be transmitted through sexual contact. Eight of these pathogens are linked to the greatest incidence of sexually transmitted disease. Of these, 4 are currently curable: syphilis, gonorrhea, chlamydia, and trichomoniasis. The other 4 are viral infections that are incurable: Hepatitis B, herpes simplex virus (HSV), human immunodeficiency virus (HIV), and human papillomavirus (HPV). STIs are spread predominantly by sexual contact, including vaginal, anal, and oral sex. Some STIs can also be transmitted from mother-to-child during pregnancy, childbirth, and breastfeeding (2, 3). The prevalence of syphilis has risen sharply in the United States over the past decade. More than 30,000 cases of syphilis were reported in 2017 at a rate of 9.5 cases per 100,000 populations. Syphilis is 8 times more common in men and is more common in the age range of 20 to 29 years. The disease is caused by the spirochete Treponema pallidum and is transmitted through sexual contact and exposure to genital sores (4, 5).
About 15% of HIV cases are globally attributed to FSWs who have unprotected sex (6). Poor socioeconomic status, criminalization of their job, multiple sexual partners, having no choice about using condoms, and poor access to proper lubricants increase occupational hazards and the prevalence of STIs in FSWs (7). The prevalence of prostitution in girls above the age of 15 years is estimated at 0.4–4.3 in Africa, 0.2–2.6 in Asia, and 0.1–1.4 in Europe (8). About one-eighth (11.8%) of the FSWs in developing countries are estimated to be infected with HIV, while only 58% of these women have access to healthcare services for HIV and other STIs (9, 10).
Prostitution is illegal and a crime in Iran, and there is no accurate statistics on its prevalence but in a study in 2017 indicated that the population size of FSW in all provincial capital cities in Iran was estimated to be 130,800 (95% UIs: 87,800–168,200). Applying the same proportion to all other major cities, our best estimate for the population size of FSW in urban Iran is 228,700 (95% UIs: 153,500–294,300) (11-13). Due to the increasing transmission of STIs through unprotected sex in Iran, the evaluation of FSWs as a high-risk group with frequent unprotected sex is necessary to control the epidemic of HIV and other STIs. The present study, therefore, examined the prevalence of viral infections and Syphilis among FSWs.
Methods
Study design, setting and population: This descriptive cross-sectional study was conducted over one year from April 2019 to April 2020. 100 FSW women in Sanandaj City (between April 2019 and April 2020) who visited the Counseling Center for Behavioral Diseases were entered into the study via purposeful (snowball) sampling method. The study population comprised women who had sex with at least one client in the past year in exchange for money, drugs, or any goods or services (food, a place to live, etc.). Women who did not consent to participation, blood test, or pap smear test were excluded.
Ethical aspects: This study was approved by the Ethics Committee of the Kurdistan University of Medical Sciences (IR.MUK.REC.1397.017) and in collaboration with the Welfare Organization and the Deputy for Health of the university. At the outset, the participants were briefed about the objective of the study, the type and method of performing the tests. Participants who were willing to participate would then fill out and sign the informed consent form. The participants were not deprived of any facilities if they did not consent to participate. As the patients had a low economic and cultural status, an infectious disease specialist was arranged to provide free-of-charge visits and some therapeutic interventions (if a disease was diagnosed). The researchers observed the confidentiality of data based on the Declaration of Helsinki.
Data collection: The participants’ demographic and socioeconomic information, the history of smoking, alcohol and drug use, childhood sexual abuse, STIs, Hepatitis B vaccination, age at the first sexual intercourse, age at starting prostitution, number of sexual intercourses per week, number of clients per week, the use of protection during intercourse, signs and symptoms of STIs in the past year, and experience of sexual violence was collected by one of the researchers via a checklist and in face-to-face interviews.
Laboratory assessments
ELISA test to diagnose viral infections: 10 ml of venous blood was taken from each participant and sent to a single laboratory to be tested for HBsAg, HBc Ab, anti-HBs, HCV Ab, and HIV Ab (kit Pishtazteb)
Rapid plasma reagin (RPR) test to diagnose syphilis infection: To perform the test, the BioniK kit was performed according to the manufacturer’s instructions.
DNA extraction for Papillomavirus : DNA was extracted, using a kit (High pure PCR Template Preparation; Roche, Germany). The DNA extraction steps were performed according to Kit instructions. Extracted DNA samples were stored in 1.5 ml microtubes at -20°C until PCR. The samples tested in vaginal sex workers were from the cervix and anal sex workers from the anal region.
PCR assay for Papillomavirus: The PCR reactions were performed in a total volume of 25 μL containing PCR Master Mix (CinnaGen, Tehran, Iran). The PCR reactions were performed according to the instructions in the studies of Mohammadpour B et al. and Salehi-Vaziri M et al.’s (14, 15). Statistical analysis: The data were analyzed in Stata 14. Qualitative variables were analyzed as frequency (percentage) and quantitative variables as means (standard deviation).
Results
A total of 138 eligible FSWs had visited the clinic and the affiliated counseling centers from April 2019 to April 2020, of whom 26 women were excluded as they did not consent to participate, and 12 women were excluded because they did not consent to a pap smear and other tests. Finally, 100 women were studied. Table 1 presents an overview of their demographic information and socioeconomic status. The mean age of the participants was 32.8 ± (14.2), ranging from 13 to 50 years. Most of the participants, 40% belonged to the 30 to 40 age group, followed by 35% belonging to the 20 to 30 age group. Most of the FSWs (94%) resided in the city and more than half of the participants (56%) did not have a high-school diploma. Moreover, 23% were illiterate, and only 5% had academic education.
Table 1.
Indicator | Estimate % | 95%CI |
---|---|---|
Age group | ||
<20 | 4% | 1.1 – 9.9 |
20 - 30 | 35% | 25.7 – 45.2 |
30 - 40 | 40% | 30.3 – 50.3 |
>40 | 21% | 13.5 – 30.3 |
Location | ||
Urban | 94% | 87.4 – 97.8 |
rural | 6% | 2.2 – 12.6 |
Education | ||
illiterate | 23% | 15.2 – 32.5 |
under diploma | 56% | 45.7 – 65.9 |
diploma | 16% | 9.4 – 24.7 |
graduated | 5% | 1.6 – 11.3 |
Marital status | ||
single | 15% | 8.6 – 23.5 |
married | 37% | 27.6 – 47.2 |
Divorced/ widowed | 48% | 37.9 – 58.2 |
Having a child | ||
yes | 78% | 68.6 – 85.7 |
no | 22% | 14.3 – 31.4 |
Imprisonment history | ||
yes | 50% | 39.8 – 60.2 |
no | 50% | 39.8 – 60.2 |
Smoking | ||
yes | 57% | 46.7 – 66.9 |
no | 43% | 33.1 – 53.3 |
Alcohol consumption | ||
yes | 59% | 48.7 – 68.7 |
no | 41% | 31.3 – 51.3 |
About 51% reported a history of drug use, of whom, 20% were current drug users at the time of the interview. The most frequently used substance was hashish 62%, followed by methadone 29%. Injecting drug users comprised 14% of the addicted women. The history of alcohol use and smoking was positive in 59% and 57%, respectively. Of those with a positive history of smoking, 38% were current smokers at the time of the interview. A history of imprisonment was reported in 50%. The mean age of the first sexual intercourse was 19.2 ± (6.8) years, 76% had the first sexual intercourse between the ages of 16 to 20 years, and 2% reported the age of the first sexual intercourse to be less than 10 years. Childhood sexual abuse was reported in 28%. The most frequent age range of starting the job was 21 to 25 years (31%), followed by 16 to 20 years (30%). 11% percent had started prostitution when they were 10 to 15 years old. The participants had 4.5 sexual relations per week on average. In terms of protected sex, 31% reported that they always used a condom when having sex with their clients. However, 49% used a condom occasionally, and 20% never used a condom. All new infections were among those who had never used condoms, and two cases of papilloma infection were among those who did not use condoms consistently. As per STIs, 47% of the FSWs reported at least one STI in the past year, with the most prevalent one being vaginal discharge (39%). About half of the women (52%) had never had a pap smear test before the interview, and only 29% had had a pap smear test in the past year. 43% had been vaccinated against hepatitis B, and 6% against HPV. After vaccination against hepatitis B and HPV no one became infected.71% had been tested for HIV in the past 12 months, while 19% did not know about such a test or where to be tested. Two people had coinfection with HCV and HIV and one person HIV, HBV and HCV. Pregnancy occurred in 16% of them because of providing sexual services, of whom 69% had an abortion (table 2).
Table 2.
Indicator | Estimate % | 95%CI |
---|---|---|
Age at first intercourse | ||
<15 | 2% | 0.2 – 7.0 |
16 -20 | 76% | 66.4 – 84.0 |
21 - 25 | 15% | 8.6 – 23.5 |
26 - 30 | 6% | 2.2 – 12.6 |
>30 | 1% | 0.0 – 5.4 |
Age at first commercial sex | ||
<15 | 11% | 5.6 – 18.8 |
16 -20 | 30% | 21.2 – 40.0 |
21 - 25 | 31% | 22.1 – 41.0 |
26 - 30 | 13% | 7.1 – 21.2 |
>30 | 15% | 8.6 – 23.5 |
Number of Clients per week | ||
1-2 | 28% | 19.5 – 37.9 |
3-6 | 38% | 28.5 – 48.3 |
≥6 | 34% | 24.8 – 44.2 |
Condom use | ||
Always | 31% | 22.1 – 41.0 |
sometimes | 49% | 38.9 – 59.2 |
Never | 20% | 12.7 – 29.2 |
History of drug use | ||
Yes | 51% | 40.8 – 61.1 |
No | 49% | 38.9 – 59.2 |
Drug use at Interview time | ||
Yes | 20% | 12.7 – 29.2 |
No | 80% | 70.8 – 87.3 |
injection drug use | ||
Yes | 14% | 7.9 – 22.4 |
No | 86% | 77.6 – 92.1 |
History of STI symptoms in the last year | ||
Yes | 47% | 36.9 – 57.2 |
No | 53% | 42.8 – 63.1 |
History of HIV testing in the last year | ||
Yes | 71% | 61.1 – 79.6 |
No | 29% | 20.4 – 38.9 |
History of pap smear test in the last year | ||
Yes | 29% | 20.4 – 38.9 |
No | 71% | 61.1 – 79.6 |
History of HBV vaccination | ||
Yes | 43% | 33.1 – 53.3 |
No | 57% | 46.7 – 66.9 |
History of HPV vaccination | ||
Yes | 6% | 2.2 – 12.6 |
No | 94% | 87.4 – 97.8 |
Pregnancy record at commercial sex | ||
Yes | 16% | 9.4 – 24.7 |
No | 84% | 75.3 – 90.6 |
History of Childhood Sexual Abuse | ||
Yes | 27.8% | 19.2 – 37.9 |
No | 72.2% | 62.1 – 80.8 |
Record of physical violence at commercial sex | ||
Yes | 66% | 55.8 – 75.2 |
No | 34% | 24.8 – 44.2 |
Of the 100 SWFs, 6 (6%) were infected with HIV (4 were aware of their disease, and 2 were diagnosed in this study); 1 (1%) had hepatitis B (HBsAb), HBC Ab in 4%, and Anti HBsAb in 47% were positive), and 2 (2%) were HCV positive. Only 1 (1%) of women were suspected of syphilis. Based on the PCR test results, HPV was found in 16(16%) samples. Type 16 was observed in 1 sample (6% of HPV positive cases, and 1% of the total studied pap smears), type 18 in 4 samples (25% of the HPV positive cases, and 4% of the total studied pap smears), types 6 and 11 together in 1 sample (6% of the HPV positive cases, and 1% of the total studied pap smears). The other 10 samples had other types of HPV that were not studied (table 3). All HIV-positive women were between 40 and 50 years old. Five of the HIV-positive people had received an HBV vaccine. In one participant, despite being vaccinated, HBsAb had a titer of 7.7, indicating that he was still susceptible to the disease. Another person tested positive for HCV Ab and HBcAb, but tested negative for HBsAg or HBs Ab, indicating HCV infection and a window period or acute exacerbation or past hepatitis B infection. Only one serologically based hepatitis B infection was found to be HBc Ab positive and had a low HBs Ab titer. The 45-year-old woman tested negative for HIV, HCV, and HPV PCR. Four of the women were HBc Ab positive (one had a low HBs Ab but a positive HBs Ab and HBs Ag. The second was HIV and HCV positive, already infected with HBV but HBs Ab not yet elevated. The third person had only HBc Ab and HBs Ab positive, which may have been first infected and then converted to HBsAg. The fourth person had HBs Ab, HBs Ag, and HBc Ab positive this finding can indicate that the patient has been infected with hepatitis B virus, but it was the beginning of the conflict and will gradually disappear with the increase of the antigen antibody. That is, if the patient's test is repeated after a few weeks, HBsAg will be negative and HBsAb and HBcAb will be positive.
Table 3.
Indicator | Estimate % | 95%CI |
---|---|---|
HIV Positive | 6% | 2.2 – 12.6 |
HBV Positive | 1% | 0.0 – 5.4 |
HCV Positive | 2% | 0.2 – 7.0 |
HPV Positive | 16% | 9.4 –24.7 |
RPR Positive | 1% | 0.0 – 5.4 |
Discussion
This study examined the prevalence of viral infections in the FSW population and provides information on lifestyle and high-risk behaviors. As prostitution is illegal in Iran, FSWs do not receive services and scant information is available on them; the results of this study can, therefore, help enact policies to prevent and control the transmission of STIs in society. Based on the findings, 6% of the FSWs had HIV, 1% had hepatitis B, 2% had hepatitis C, and 16% had HPV. All of the infected FSW with HIV, HBV, and HCV had history of drug abuse.
Other studies conducted in the past decade have reported the HIV prevalence to be 0–5% among FSWs in Iran (16-18). In a 2013 study in Shiraz (in a southern Iranian province), the prevalence of HIV among FSWs was 4.7%. 70% reported drug use, of whom only 16% were injection drug users (IDUs). Moreover, unprotected sex was reported to be 24% in the previous months (18). In another study conducted in Tehran in 2012–2013, 5% of the FSWs were infected with HIV. In this study, 65.2% of the FSWs had used a condom in their last sexual intercourse, while only 49% used a condom in all their sexual relations. Moreover, 33% had been tested for HIV in the last 12 months and knew the results. Furthermore, 91% had taken narcotics at least once, 56% were active substance users at the time of the interview, and 25% were injecting drug users (IDUs) (19). In Mirzazadeh et al.’s study, the prevalence of HIV was 5%, HPV 41.8%, gonorrhea 1.3%, trichomonas 11.9%, chlamydia 6%, and syphilis 0.4–4% (20). In another study, Haraz Wong et al. indicated that the prevalence of syphilis was 2.1% and none of the people were HIV positive. The prevalence of positive test for pharyngeal chlamydia and Neisseria gonorrhoeae was 3.2% and 4.4%, respectively. However, the prevalence of urinary tract chlamydia infection and gonococcal infection were 10.6% and 0.9%, respectively (21).
In Michel Decker et al.’s study indicated that in Russian for 147 FSWs, the prevalence of HIV was 4.8%, the prevalence of chlamydia was 15%, syphilis was 11.6%, and gonorrhea was 6.8%. People ranged in age from 17 to 40. More than half (53.7%) were over 22 years old. The prevalence of sexually transmitted infections and HIV together was higher in immigrant prostitutes than in indigenous women at 42.6% and 17.4%, respectively (22).
The findings of the present study indicate that the prevalence of HIV among FSWs in this region is higher than that reported by other studies in Iran. Compared to previous studies, a higher percentage of FSWs in the current study had been tested for HIV in the last 12 months and knew the results. Moreover, fewer FSWs in this study reported using narcotics at least once, were active users, or were IDUs. Nevertheless, the indices related to unprotected sex found in the current study were higher than other studies. In HIV/AIDS modeling, Haghdoost et al. (2014) reported that the transmission pattern has shifted from unsafe injection towards unprotected sex (20). In our study, unprotected sex was the most high-risk behavior in terms of STIs transmission in this group. Based on these results, the FSWs in these regions have little awareness of HIV prevention methods. Healthcare information disseminating organizations must, therefore, raise this high-risk group’s awareness, and provide free and easy access to condoms and other forms of protection due to FSWs’ low socioeconomic status. In our results, 43 cases were vaccinated, 27 of which did not have an adequate antibody titer, which was due to the vaccine injection in the last 5 to 10 years and suggest that we should check the vaccine titer annually.
In our study, the prevalence of hepatitis B (1%) did not differ from that in the general population of Iran (1.09%) (23), but the prevalence of hepatitis C (2%) was higher than that in the general population of this country (0.16%) (24). In a study conducted in Isfahan on 100 women who had illegal sexual relations, the prevalence of hepatitis B and C was 1 and 10%, respectively (25). In a study in Tehran, the prevalence of hepatitis B and C was respectively 1 and 8% (26). These results are consistent with our study in terms of hepatitis B prevalence, but hepatitis C prevalence was much lower in our study than the cited ones. The high vaccination rate of the FSWs in the current study (43%) may explain the low prevalence of hepatitis B in them, showing that vaccination is the best strategy for mitigating the risk of HBV infection. The findings of the present study highlight the necessity of preventive interventions for this high-risk group to prevent HCV transmission in society.
In the present study, the HPV prevalence among FSWs was 16%, and the frequency of the 16 and 18 genotypes with a high oncogenic risk was 1% and 4%, respectively. A systematic review and meta-analysis on 14 studies in Iran reported the prevalence of HPV among healthy women in different Iranian provinces to be 9.4%, and the prevalence of HPV types 16 and 18 as 2.3% and 1.7%, respectively (27). Based on the latest reports published by the ICO HPV INFORMATION CENTRE in 2019 about the HPV status in Iran, the prevalence of HPV in the studied women with normal cytology was 7.4%. HPV type 16 existed in 2.2%, and type 18 in 0.6% of women with normal cervical cytology. Overall, about 2.8% of women in the general population carried HPV 16/18 in their cervical discharge (28). Therefore, the frequency of genotype 18 in the FSWs studied in the current study was higher than the general population of other cities. The high prevalence of oncogenic HPV in this study is similar to the findings of a study on a group of FSWs in Turkey; which reported HPV prevalence to be 20.1% and the HPV type 18 was the most prevalent genotype identified among the FSWs (40% of HPV positive women) (29). Due to the high prevalence of high-risk types in these patients, which is strongly correlated with cervical cancer, preventive measures, vaccination, and regular cervical cancer screening programs must be implemented for this vulnerable group.
The main limitation of this study was that most of the studied women had a low socioeconomic status. The findings should, therefore, be generalized to all FSWs in society with caution. Moreover, we did not determine the other HPV genotypes; the laboratory in which the samples were tested only had access to the positive control for genotypes 6, 11, 16, and 18, and the other genotypes could not be detected.
This study was conducted for the first time in west of Iran, showed a high prevalence of viral infection among FSWs. High-risk and unprotected sexual behaviors, which are strongly correlated with the prevalence of these infections, are also considerably prevalent in this group. These findings indicate that FSWs are a high-priority group for regular screening programs, and national HIV and cervical cancer prevention programs should preferably be concentrated on these women. Raising their awareness and educating them on how to prevent STIs and offering efficient health insurance that provides easy access to healthcare can effectively reduce the prevalence of these infections among FSWs.
Acknowledgments
We would like to thank Kurdistan University of Medical Sciences and Research Deputy of Kurdistan University of Medical Sciences for financial support.
Funding:
Funding provided by Kurdistan University of Medical Sciences (IR.MUK.REC.1397.017).
Conflict of Interests:
No potential conflict of interest was reported by the authors.
Authors’ contribution:
A.A, A.A, S.M, M.A; Contributed to writing the first draft. K.R, NSA; Contributed to all data and statistical analysis, and interpretation of data. B.M., A.B and S.A.; Contributed to the research concept, supervised the work, and revised the manuscript. All authors read and approved the final manuscript.
References
- 1.Rekart ML. Sex-work harm reduction. Lancet. 2005;366:2123–34. doi: 10.1016/S0140-6736(05)67732-X. [DOI] [PubMed] [Google Scholar]
- 2.Garcia MR, Wray AA. Sexually transmitted infections. StatPearls: StatPearls Publishing : 2021. [Accsesed May 30, 2023]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560808/ [PubMed] [Google Scholar]
- 3.McCormack D, Koons K. Sexually transmitted infections. Emerg Med Clin. 2019;37:725–38. doi: 10.1016/j.emc.2019.07.009. [DOI] [PubMed] [Google Scholar]
- 4.Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64:1–137. [PMC free article] [PubMed] [Google Scholar]
- 5.Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2017. Atlanta: US Dept Health Human Ser 2018 [Google Scholar] ; 2016. pp. 79–80. [Google Scholar]
- 6.Prüss-Ustün A, Wolf J, Driscoll T, et al. HIV due to female sex work: regional and global estimates. PloS one. 2013;8:e63476. doi: 10.1371/journal.pone.0063476. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Scorgie F, Chersich MF, Ntaganira I, et al. Socio-demographic characteristics and behavioral risk factors of female sex workers in sub-saharan Africa: a systematic review. AIDS Behav. 2012;16:920–33. doi: 10.1007/s10461-011-9985-z. [DOI] [PubMed] [Google Scholar]
- 8.Love R. Street level prostitution: a systematic literature review. Issues Ment Health Nurs. 2015;36:568–77. doi: 10.3109/01612840.2015.1020462. [DOI] [PubMed] [Google Scholar]
- 9.Tran BX, Nguyen TV, Pham QD, et al. HIV infection, risk factors, and preventive services utilization among female sex workers in the Mekong Delta Region of Vietnam. PloS one. 2014;9:e86267. doi: 10.1371/journal.pone.0086267. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.World Health Organization. Global health sector strategy on HIV/AIDS 2011-2015. Int Rev Progr. 2011:1–52. [Google Scholar]
- 11.Malery khah Langeroudi Z, Delbarpour Ahmadi S, Esmaeili M. Barriers of condom use among female sex workers in Tehran, a qualitative study. J Sch Public Health Inst Public Health Res. 2014;12:23–34. [Google Scholar]
- 12.Allahqoli L, Rahmani A. Social determinants of sex work among female sex workers in tehran. Health Educ Health Promot. 2017;5:5–17. [Google Scholar]
- 13.Sharifi H, Karamouzian M, Baneshi MR, et al. Population size estimation of female sex workers in Iran: synthesis of methods and results. PloS one. 2017;12:e0182755. doi: 10.1371/journal.pone.0182755. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Mohammadpour B, Khodabandehloo M, Motazakker M. The prevalence and association of human papillomavirus with esophageal cancer in West Azerbaijan, Iran. Int J Cancer Manag. 2019:12. [Google Scholar]
- 15.Salehi-Vaziri M, Sadeghi F, Bokharaei-Salim F, et al. The prevalence and genotype distribution of human papillomavirus in the genital tract of males in Iran. Jundishapur J Microbiol. 2015;8:e21912. doi: 10.5812/jjm.21912. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Kassaian N, Ataei B, Yaran M, et al. HIV and other sexually transmitted infections in women with illegal social behavior in Isfahan, Iran. Adv Biomed Res. 2012;1:5. doi: 10.4103/2277-9175.94427. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Navadeh S, Mirzazadeh A, Mousavi L, et al. HIV, HSV2 and syphilis prevalence in female sex workers in Kerman, South-East Iran; using respondent-driven sampling. Iran J Public Health. 2012;41:60–65. [PMC free article] [PubMed] [Google Scholar]
- 18.Kazerooni PA, Motazedian N, Motamedifar M, et al. P3 193 the prevalence of HIV and STIs among female sex workers in Shiraz, South of Iran: by Respondent Driven Sampling. Sex Transm Infect. 2013;89:A208–A. doi: 10.1177/0956462413496227. [DOI] [PubMed] [Google Scholar]
- 19.Kazerooni PA, Motazedian N, Motamedifar M, et al. The prevalence of human immunodeficiency virus and sexually transmitted infections among female sex workers in Shiraz, South of Iran: by respondent-driven sampling. Int J STD AIDS. 2014;25:155–61. doi: 10.1177/0956462413496227. [DOI] [PubMed] [Google Scholar]
- 20.Haghdoost AA, Mostafavi E, Mirzazadeh A, et al. Modelling of HIV/AIDS in Iran up to 2014. J AIDS HIV Res. 2011;3:231–9. [Google Scholar]
- 21.Wong HT, Lee KC, Chan DP. Community-based sexually transmitted infection screening and increased detection of pharyngeal and urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infections in female sex workers in Hong Kong. Sex Transm Dis. 2015;42:185–191. doi: 10.1097/OLQ.0000000000000257. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Decker MR, Wirtz AL, Baral SD, et al. Injection drug use, sexual risk, violence and STI/HIV among Moscow female sex workers. Sex Transm Infect. 2012;88:278–83. doi: 10.1136/sextrans-2011-050171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Rezaei N, Asadi-Lari M, Sheidaei A, et al. Epidemiology of hepatitis B in Iran from 2000 to 2016: a systematic review and meta-regression analysis. Arch Iran Med. 2020;23:189–96. [PubMed] [Google Scholar]
- 24.Alavian SM, Ahmadzadedasl M, Bagheri LK, et al. Hepatitis C infection in the general population of Iran: a systematic review. Hepat Mon. 2009;9:211–23. [Google Scholar]
- 25.Kassaian N, Ataei B, Yaran M, et al. Hepatitis B and C among women with illegal social behavior in Isfahan, Iran: Seroprevalence and associated factors. Hepat Mon. 2011;11:368–371. [PMC free article] [PubMed] [Google Scholar]
- 26.Moayedi-Nia S, Bayat Jozani Z, Esmaeeli Djavid G, et al. HIV, HCV, HBV, HSV, and syphilis prevalence among female sex workers in Tehran, Iran, by using respondent-driven sampling. Aids Care. 2016;28:487–90. doi: 10.1080/09540121.2015.1109582. [DOI] [PubMed] [Google Scholar]
- 27.Malary M, Moosazadeh M, Hamzehgardeshi Z, et al. The prevalence of cervical human papillomavirus infection and the most at-risk genotypes among Iranian healthy women: A systematic review and meta-analysis. Int J Prev Med. 2016;7:70. doi: 10.4103/2008-7802.181756. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Bruni L, Barrionuevo-Rosas L, Albero G, et al. Human papillomavirus and related diseases report. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). 2019;7:26–42. [Google Scholar]
- 29.Ersan G, Kose S, Senger SS, et al. The prevalence and risk factors of human papillomavirus in female sex workers. Eurasian J Med. 2013;45:16–20. doi: 10.5152/eajm.2013.03. [DOI] [PMC free article] [PubMed] [Google Scholar]